TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 118 filers reported holding TG THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $94,000 | -12.1% | 2,830 | +2.3% | 0.01% | -7.7% |
| Q2 2021 | $107,000 | +12.6% | 2,767 | +40.7% | 0.01% | +18.2% |
| Q1 2021 | $95,000 | -52.3% | 1,966 | -48.6% | 0.01% | -52.2% |
| Q4 2020 | $199,000 | +42.1% | 3,822 | -21.0% | 0.02% | +35.3% |
| Q3 2020 | $140,000 | +164.2% | 4,837 | -62.4% | 0.02% | +30.8% |
| Q4 2018 | $53,000 | -30.3% | 12,858 | -5.1% | 0.01% | -13.3% |
| Q3 2018 | $76,000 | -71.4% | 13,556 | -33.0% | 0.02% | -71.7% |
| Q2 2018 | $266,000 | -26.9% | 20,223 | -21.2% | 0.05% | -30.3% |
| Q1 2018 | $364,000 | +66.2% | 25,666 | -3.9% | 0.08% | +76.7% |
| Q4 2017 | $219,000 | -11.0% | 26,701 | +28.6% | 0.04% | -2.3% |
| Q3 2017 | $246,000 | +27.5% | 20,763 | +8.3% | 0.04% | +25.7% |
| Q2 2017 | $193,000 | +157.3% | 19,179 | +199.7% | 0.04% | +218.2% |
| Q1 2017 | $75,000 | – | 6,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |